Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Pioglitazone on Neointima Volume and Inflammatory Markers in Diabetic Patients

NCT00494559 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT00494559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00494559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Pioglitazone on Neointima Volume and Inflammatory Markers in Diabetic Patients
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
July 31, 2015
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery stenosis, diabetes mellitus